RDHL
Price:
$6.35
Market Cap:
$8.09M
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in P...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-01-07
Stock Exchange
NASDAQ
Ticker
RDHL
According to RedHill Biopharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.70M. This represents a change of -99.06% compared to the average of 393.90M of the last 4 quarters.
The mean historical Enterprise Value of RedHill Biopharma Ltd. over the last ten years is 3.05B. The current 3.70M Enterprise Value has changed -87.87% with respect to the historical average. Over the past ten years (40 quarters), RDHL's Enterprise Value was at its highest in in the September 2020 quarter at 9.59B. The Enterprise Value was at its lowest in in the June 2023 quarter at 18.34K.
Average
3.05B
Median
3.10B
Minimum
232.05M
Maximum
7.42B
Discovering the peaks and valleys of RedHill Biopharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 65.51%
Maximum Annual Enterprise Value = 7.42B
Minimum Annual Increase = -89.54%
Minimum Annual Enterprise Value = 232.05M
Year | Enterprise Value | Change |
---|---|---|
2023 | 232.05M | -27.47% |
2022 | 319.94M | -89.54% |
2021 | 3.06B | -58.75% |
2020 | 7.42B | 65.51% |
2019 | 4.48B | 42.72% |
2018 | 3.14B | 40.50% |
2017 | 2.23B | -29.77% |
2016 | 3.18B | -10.30% |
2015 | 3.55B | 23.13% |
2014 | 2.88B | 57.54% |
The current Enterprise Value of RedHill Biopharma Ltd. (RDHL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.20B
5-year avg
3.10B
10-year avg
3.05B
RedHill Biopharma Ltd.’s Enterprise Value is less than Organogenesis Holdings Inc. (413.14M), less than Lifecore Biomedical, Inc. (411.23M), less than Taro Pharmaceutical Industries Ltd. (1.25B), less than Collegium Pharmaceutical, Inc. (1.77B), less than Aquestive Therapeutics, Inc. (279.92M), greater than Evoke Pharma, Inc. (942.42K), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Guardion Health Sciences, Inc. (-10475955.00), greater than AcelRx Pharmaceuticals, Inc. (-587846.00), less than Petros Pharmaceuticals, Inc. (6.24M), less than Cumberland Pharmaceuticals Inc. (39.26M), less than Agile Therapeutics, Inc. (7.87M), greater than PainReform Ltd. (-101665.00), less than China Pharma Holdings, Inc. (6.93M), less than Halo Collective Inc. (16.67M), less than Alimera Sciences, Inc. (362.58M), greater than China SXT Pharmaceuticals, Inc. (-8067215.00), less than Alpha Teknova, Inc. (482.89M), less than Cyclo Therapeutics, Inc. (16.22M),
Company | Enterprise Value | Market cap |
---|---|---|
413.14M | $399.81M | |
411.23M | $279.89M | |
1.25B | $1.62B | |
1.77B | $937.19M | |
279.92M | $320.95M | |
942.42K | $7.28M | |
-6593458674.00 | $7.25M | |
-10475955.00 | $4.35M | |
-587846.00 | $14.58M | |
6.24M | $2.89M | |
39.26M | $35.25M | |
7.87M | $10.43M | |
-101665.00 | $2.62M | |
6.93M | $3.64M | |
16.67M | $15.08K | |
362.58M | $301.29M | |
-8067215.00 | $1.36M | |
482.89M | $458.45M | |
16.22M | $17.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RedHill Biopharma Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RedHill Biopharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is RedHill Biopharma Ltd.'s Enterprise Value?
What is the highest Enterprise Value for RedHill Biopharma Ltd. (RDHL)?
What is the 3-year average Enterprise Value for RedHill Biopharma Ltd. (RDHL)?
What is the 5-year average Enterprise Value for RedHill Biopharma Ltd. (RDHL)?
How does the current Enterprise Value for RedHill Biopharma Ltd. (RDHL) compare to its historical average?